摘要
探讨了在新生儿呼吸窘迫综合征的治疗方案中实施肺泡表面活性物质联合无创通气治疗的效果及其对患儿呼吸指标的影响。以临城县人民医院收治的70例新生儿呼吸窘迫综合征患儿为研究对象,实施单双号分发法,将其分成试验组和参照组两个小组,之后对两组患儿实施不同的治疗方案,参照组患儿(n=35)施以无创通气治疗,试验组患儿(n=35)施以肺泡表面活性物质联合无创通气治疗,详细记录两组患儿的治疗效果、呼吸指标、心功能指标、并发症发生情况、治疗相关指标等数据并予以分析。研究发现,在新生儿呼吸窘迫综合征的治疗方案中,实施肺泡表面活性物质联合无创通气治疗方式可有效提升患儿的治疗效果,降低其发生并发症的概率,同时可使患儿的心功能指标、呼吸指标及治疗相关指标均得到明显改善,临床效果十分显著。
To explore the effect of pulmonary surfactant combined with non-invasive ventilation in the treatment of neonatal respiratory distress syndrome and its influence on the respiratory indicators of children.70 neonates with respiratory distress syndrome admitted to Lincheng People’s Hospital were taken as the research object.They were divided into two groups:the test group and the reference group.After that,diff erent treatment schemes were implemented for the two groups of children.The reference group(n=35)was given non-invasive ventilation,and the test group(n=35)was given alveolar surfactant combined with non-invasive ventilation.The treatment effects,respiratory indicators Cardiac function indicators,complications,treatment related indicators and other data were analyzed.The study found that,in the treatment scheme of neonatal respiratory distress syndrome,the combination of pulmonary surfactant and non-invasive ventilation can effectively improve the treatment effect of children,reduce the probability of complications,and significantly improve the cardiac function indicators,respiratory indicators and treatment related indicators of children.The clinical application is very significant.
作者
赵翠格
ZHAO Cuige(Lincheng People’s Hospital,Lincheng,Hebei 054300)
出处
《科技与健康》
2022年第6期40-42,共3页
Technology and Health
关键词
呼吸指标
无创通气
新生儿呼吸窘迫综合征
肺泡表面活性物质
respiratory index
noninvasive ventilation
neonatal respiratory distress syndrome
alveolar surfactant
